Logo

AstraZeneca Entered into a Two-Year Collaboration with Thorne HealthTech for Disease Discovery System to Advance Novel Product Development

Share this
AstraZeneca Entered into a Two-Year Collaboration with Thorne HealthTech for Disease Discovery System to Advance Novel Product Development

AstraZeneca Entered into a Two-Year Collaboration with Thorne HealthTech for Disease Discovery System to Advance Novel Product Development

Shots:

  • The collaboration focuses on Thorne's disease discovery platform into AZ for further analysis, gaining insight for additional uses of AZ molecules & will identify novel and biologically plausible drug targets
  • The collaboration will provide innovative AI-driven technologies for drug discovery & will identify novel and biologically plausible drug targets. Thorne's cloud-based AI illness discovery engine combines evidence from biology & chemistry to produce compound discoveries for new product development in the pharmaceutical & nutrition industries
  • The system uses a multi-omic platform & Thorne’s AI model which have been validated by numerous independent clinical studies in peer-reviewed publications

Ref: PR Newswire | Image: AstraZeneca

Click here to­ read the full press release 

Neha

Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions